127 related articles for article (PubMed ID: 8675728)
21. Surgical excision margins for primary cutaneous melanoma.
Sladden MJ; Balch C; Barzilai DA; Berg D; Freiman A; Handiside T; Hollis S; Lens MB; Thompson JF
Cochrane Database Syst Rev; 2009 Oct; (4):CD004835. PubMed ID: 19821334
[TBL] [Abstract][Full Text] [Related]
22. One-step surgical removal of cutaneous melanoma with surgical margins based on preoperative ultrasound measurement of the thickness of the melanoma.
Chaput L; Laurent E; Pare A; Sallot A; Mourtada Y; Ossant F; Vaillant L; Patat F; Machet L
Eur J Dermatol; 2018 Apr; 28(2):202-208. PubMed ID: 29620001
[TBL] [Abstract][Full Text] [Related]
23. A policy of selective excision for primary cutaneous malignant melanoma.
Taylor BA; Hughes LE
Eur J Surg Oncol; 1985 Mar; 11(1):7-13. PubMed ID: 3987915
[TBL] [Abstract][Full Text] [Related]
24. Management of malignant melanoma.
Kroon BB; Nieweg OE
Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
[TBL] [Abstract][Full Text] [Related]
25. Colorectal cancer pathology reporting: a regional audit.
Bull AD; Biffin AH; Mella J; Radcliffe AG; Stamatakis JD; Steele RJ; Williams GT
J Clin Pathol; 1997 Feb; 50(2):138-42. PubMed ID: 9155695
[TBL] [Abstract][Full Text] [Related]
26. Quality of histopathological reporting on melanoma and influence of use of a synoptic template.
Haydu LE; Holt PE; Karim RZ; Madronio CM; Thompson JF; Armstrong BK; Scolyer RA
Histopathology; 2010 May; 56(6):768-74. PubMed ID: 20546342
[TBL] [Abstract][Full Text] [Related]
27. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.
Veronesi U; Cascinelli N; Adamus J; Balch C; Bandiera D; Barchuk A; Bufalino R; Craig P; De Marsillac J; Durand JC
N Engl J Med; 1988 May; 318(18):1159-62. PubMed ID: 3079582
[TBL] [Abstract][Full Text] [Related]
28. ACP best practice no 162. The histological reporting of melanoma. Association of Clinical Pathologists.
Calonje E
J Clin Pathol; 2000 Aug; 53(8):587-90. PubMed ID: 11002760
[TBL] [Abstract][Full Text] [Related]
29. Primary excision margins and sentinel lymph node biopsy in clinically node-negative melanoma of the trunk or extremities.
Wright F; Spithoff K; Easson A; Murray C; Toye J; McCready D; Petrella T;
Clin Oncol (R Coll Radiol); 2011 Nov; 23(9):572-8. PubMed ID: 21605963
[TBL] [Abstract][Full Text] [Related]
30. Excision versus incision biopsy in the management of malignant melanoma.
Sharma KS; Lim P; Brotherston MT
J Dermatolog Treat; 2016; 27(1):88-90. PubMed ID: 25886086
[TBL] [Abstract][Full Text] [Related]
31. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
Fisher NM; Schaffer JV; Berwick M; Bolognia JL
J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
[TBL] [Abstract][Full Text] [Related]
32. Breslow Thickness Measurements of Melanomas Around American Joint Committee on Cancer Staging Cut-Off Points: Imprecision and Terminal Digit Bias Have Important Implications for Staging and Patient Management.
Ge L; Vilain RE; Lo S; Aivazian K; Scolyer RA; Thompson JF
Ann Surg Oncol; 2016 Aug; 23(8):2658-63. PubMed ID: 27075324
[TBL] [Abstract][Full Text] [Related]
33. A retrospective comparison between preoperative and postoperative Breslow depth in primary cutaneous melanoma: how preoperative shave biopsies affect surgical management.
Saco M; Thigpen J
J Drugs Dermatol; 2014 May; 13(5):531-6. PubMed ID: 24809875
[TBL] [Abstract][Full Text] [Related]
34. The changing controversy over surgical resection margins for stage I cutaneous melanoma.
Green MS
Mt Sinai J Med; 1991 Sep; 58(4):341-6. PubMed ID: 1944321
[TBL] [Abstract][Full Text] [Related]
35. Reproducibility of AJCC staging parameters in primary cutaneous melanoma: an analysis of 4,924 cases.
Niebling MG; Haydu LE; Karim RZ; Thompson JF; Scolyer RA
Ann Surg Oncol; 2013 Nov; 20(12):3969-75. PubMed ID: 23851608
[TBL] [Abstract][Full Text] [Related]
36. Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution.
Mariani G; Erba P; Manca G; Villa G; Gipponi M; Boni G; Buffoni F; Suriano S; Castagnola F; Bartolomei M; Strauss HW
J Surg Oncol; 2004 Mar; 85(3):141-51. PubMed ID: 14991886
[TBL] [Abstract][Full Text] [Related]
37. Preoperative 15-MHz ultrasound assessment of tumor thickness in malignant melanoma.
Fernández Canedo I; de Troya Martín M; Fúnez Liébana R; Rivas Ruiz F; Blanco Eguren G; Blázquez Sánchez N
Actas Dermosifiliogr; 2013 Apr; 104(3):227-31. PubMed ID: 22938997
[TBL] [Abstract][Full Text] [Related]
38. Interobserver variability of histopathological prognostic parameters in cutaneous malignant melanoma: impact on patient management.
Eriksson H; Frohm-Nilsson M; Hedblad MA; Hellborg H; Kanter-Lewensohn L; Krawiec K; Lundh Rozell B; Månsson-Brahme E; Hansson J
Acta Derm Venereol; 2013 Jul; 93(4):411-6. PubMed ID: 23306667
[TBL] [Abstract][Full Text] [Related]
39. Excision biopsy of malignant melanoma by general practitioners in south east Scotland 1982-91.
Herd RM; Hunter JA; McLaren KM; Chetty U; Watson AC; Gollock JM
BMJ; 1992 Dec; 305(6867):1476-8. PubMed ID: 1493395
[TBL] [Abstract][Full Text] [Related]
40. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
